NOVEL ICP: NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients

Sponsor
Emory University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04548596
Collaborator
University of California, San Francisco (Other), National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
432
3
110.7
144
1.3

Study Details

Study Description

Brief Summary

This is an observational study in neurocritical care units at University of California San Francisco Medical Center (UCSFMC), Zuckerberg San Francisco General Hospital (ZSFGH), and Duke University Medical Center. In this study, the investigators will primarily use the monitor mode of the Transcranial Doppler (TCD, non-invasive FDA approved device) to record cerebral blood flow velocity (CBFV) signals from the Middle Cerebral Artery and Internal Carotid Artery. TCD data and intracranial pressure (ICP) data will be collected in the following four scenarios. Each recording is up to 60 minutes in length.

Multimodality high-resolution physiological signals will be collected from brain injured patients: traumatic brain injury, subarachnoid and intracerebral hemorrhage, liver failure, and ischemic stroke. This is not a hypothesis-driven study but rather a signal database development project with a goal to collect multimodality brain monitoring data to support development and validation of algorithms that will be useful for future brain monitoring devices. In particular, the collected data will be used to support:

Development and validation of noninvasive intracranial pressure (nICP) algorithms.

Development and validation of continuous monitoring of neurovascular coupling state for brain injury patients

Development and validation of noninvasive approaches of detecting elevated ICP state.

Development and validation of approaches to determine most likely causes of ICP elevation.

Development and validation of approaches to detect acute cerebral hemodynamic response to various neurovascular procedures.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Transcranial Doppler

Study Design

Study Type:
Observational
Anticipated Enrollment :
432 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
Actual Study Start Date :
Sep 10, 2014
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Outcome Measures

Primary Outcome Measures

  1. Multimodality high-resolution signals from brain-injured patients [at completion of the study up to 3 years]

    The investigators aim to collect multimodality high-resolution physiological signals from brain-injured patients. This is not a hypothesis-driven study but rather a signal database development project with a goal to collect multimodality brain monitoring data to support development and validation of algorithms that will be useful for future brain monitoring devices.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Male or female subjects 18 years of age and older

  2. Subjects who have an ICP monitoring device that allows for 30 minutes of continuous monitoring

Exclusion Criteria:
  1. Unstable medical illness such as recordings might interfere with medical care

  2. Subjects that don't have a viable temporal window to insonate the middle cerebral artery (MCA)

  3. Subjects that have skull fractures that the attending or study investigators believe participation would add clinical risk to the subject

  4. Subjects that had hemicraniectomy and are still without bone flap

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California San Francisco San Francisco California United States 94143
2 Emory University Atlanta Georgia United States 30322
3 Duke University Durham North Carolina United States 27710

Sponsors and Collaborators

  • Emory University
  • University of California, San Francisco
  • National Institute of Neurological Disorders and Stroke (NINDS)

Investigators

  • Principal Investigator: Xiao Hu, Emory University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xiao Hu, Acting Professor, Emory University
ClinicalTrials.gov Identifier:
NCT04548596
Other Study ID Numbers:
  • STUDY00004039
  • Pro00105151
  • R01NS106905
First Posted:
Sep 14, 2020
Last Update Posted:
Aug 23, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 23, 2022